Literature DB >> 19135598

Beta blockers for asthma: a double-edged sword.

Brian J Lipworth1, Peter A Williamson.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19135598     DOI： 10.1016/S0140-6736(09)60018-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Effects of hydrocortisone on acute β-adrenoceptor blocker and histamine induced bronchoconstriction.

Authors:  Philip M Short; Peter A Williamson; Brian J Lipworth
Journal:  Br J Clin Pharmacol       Date:  2012-05       Impact factor: 4.335

Review 2.  Clinical implications of the intrinsic efficacy of beta-adrenoceptor drugs in asthma: full, partial and inverse agonism.

Authors:  Nicola A Hanania; Burton F Dickey; Richard A Bond
Journal:  Curr Opin Pulm Med       Date:  2010-01       Impact factor: 3.155

3.  Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study.

Authors:  Philip M Short; Samuel I W Lipworth; Douglas H J Elder; Stuart Schembri; Brian J Lipworth
Journal:  BMJ       Date:  2011-05-10

4.  Preadmission beta-blocker use and 30-day mortality among patients in intensive care: a cohort study.

Authors:  Steffen Christensen; Martin Berg Johansen; Else Tønnesen; Anders Larsson; Lars Pedersen; Stanley Lemeshow; Henrik Toft Sørensen
Journal:  Crit Care       Date:  2011-03-07       Impact factor: 9.097

Review 5.  Beta-Adrenergic Agonists.

Authors:  Giovanni Barisione; Michele Baroffio; Emanuele Crimi; Vito Brusasco
Journal:  Pharmaceuticals (Basel)       Date:  2010-03-30

Review 6.  The safety of long-acting β2-agonists in the treatment of stable chronic obstructive pulmonary disease.

Authors:  Marc L Decramer; Nicola A Hanania; Jan O Lötvall; Barbara P Yawn
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-01-25

7.  In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based study.

Authors:  Te-Wei Ho; Yi-Ju Tsai; Sheng-Yuan Ruan; Chun-Ta Huang; Feipei Lai; Chong-Jen Yu
Journal:  PLoS One       Date:  2014-12-09       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.